• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重类别对接受体外膜肺氧合(ECMO)治疗的患者的死亡率没有影响。

Weight Categories Have no Impact on Mortality in Patients Treated with Extracorporeal Membrane Oxygenation (ECMO).

作者信息

Marefat Meredith, Hashemzadeh Mehrtash, Movahed Mohammad Reza

机构信息

Department of Medicine, University of Arizona Sarver Heart Center, Tucson, AZ, USA.

Department of Medicine, University of Arizona, Phoenix, AZ, USA.

出版信息

J Intensive Care Med. 2025 Jun 27:8850666251351574. doi: 10.1177/08850666251351574.

DOI:10.1177/08850666251351574
PMID:40579396
Abstract

BackgroundExtracorporeal Membrane Oxygenation (ECMO) is a critical support system for patients with acute and severe cardiac and respiratory failure. This study investigates the impact of different patient body weight categories on the mortality rates of patients undergoing ECMO support.MethodsUsing the Nationwide Sample (NIS) database and ICD-10 codes for 2016 to 2020 in adults over age 18, we evaluated total mortality based on weight categories compared to normal weights using univariate and multivariate analyses.ResultsA total population of 47 990 patients underwent ECMO insertion with a mean age of 52.6 years. Total mortality was 45.7%. Patients with cachexia, overweight, and obesity had similar mortality to normal-weight patients. (Cachexia: 43.75%, normal weight: 46.30%,  = .60, OR = 0.90, 95% CI: 0.61-1.33, overweight 42.31%,  = .69, OR = 0.85, 95% CI: 0.38-1.89, and obesity 45.73%,  = .73, OR = 0.98, 95% CI: 0.85-1.12). However, morbid obesity had the lowest mortality in the univariate analysis (41.89%,  = .01, OR = 0.84, 95% CI: 0.73-0.96) but was not significant in the multivariate analysis ( = .66, OR: 0.97, CI: 0.83-1.12). Separating peripheral veno-arterial versus veno-venous ECMO showed similar results with similar mortalities based on weight categories.ConclusionsOur data suggest that the 'obesity paradox' does not exist in ECMO-treated patients, with no effect of weight on total mortality . Further research is necessary to understand the underlying factors contributing to these outcomes.

摘要

背景

体外膜肺氧合(ECMO)是急性重症心功能和呼吸功能衰竭患者的关键支持系统。本研究调查了不同体重类别的患者对接受ECMO支持患者死亡率的影响。

方法

使用全国样本(NIS)数据库以及2016年至2020年18岁以上成年人的国际疾病分类第十版(ICD - 10)编码,我们通过单因素和多因素分析,基于体重类别与正常体重相比评估总死亡率。

结果

共有47990例患者接受了ECMO植入,平均年龄为52.6岁。总死亡率为45.7%。恶病质、超重和肥胖患者的死亡率与正常体重患者相似。(恶病质:43.75%,正常体重:46.30%,P = 0.60,OR = 0.90,95%CI:0.61 - 1.33;超重:42.31%,P = 0.69,OR = 0.85,95%CI:0.38 - 1.89;肥胖:45.73%,P = 0.73,OR = 0.98,95%CI:0.85 - 1.12)。然而,病态肥胖在单因素分析中死亡率最低(41.89%,P = 0.01,OR = 0.84,95%CI:0.73 - 0.96),但在多因素分析中无统计学意义(P = 0.66,OR:0.97,CI:0.83 - 1.12)。将外周静脉 - 动脉与静脉 - 静脉ECMO分开分析显示,基于体重类别的死亡率相似,结果类似。

结论

我们的数据表明,在接受ECMO治疗的患者中不存在“肥胖悖论”,体重对总死亡率没有影响。有必要进行进一步研究以了解导致这些结果的潜在因素。

相似文献

1
Weight Categories Have no Impact on Mortality in Patients Treated with Extracorporeal Membrane Oxygenation (ECMO).体重类别对接受体外膜肺氧合(ECMO)治疗的患者的死亡率没有影响。
J Intensive Care Med. 2025 Jun 27:8850666251351574. doi: 10.1177/08850666251351574.
2
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
3
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.肥胖症减肥干预措施以提高子宫内膜癌女性的生存率。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Effects of levosimendan on the outcome of veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis.左西孟旦对静脉-动脉体外膜肺氧合结局的影响:一项系统评价和荟萃分析
Clin Res Cardiol. 2024 Apr;113(4):509-521. doi: 10.1007/s00392-023-02208-1. Epub 2023 May 22.